Why AVTX? Avalo Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
AVTX
$21.57-1.30 (-5.68%)
Market ClosedLast close May 8
Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States.